15 Followers on Owler

BioIncept

Read more
Brian K. Foster's photo - CEO of BioIncept

CEO

Brian K. Foster

CEO Approval Rating

88/100

Est. Annual Revenue
$7.3M
Agree?
Est. Employees
25
Agree?
Funding
$15.6M

BioIncept Competitors and Alternatives

1
2
3
4
5
6
7
8
9
10
See more competitor data

BioIncept News

BioIncept Blogs

BioIncept Headquarters

575 5th Avenue Suite 15-103

New York, New York10017

203-222-7386

Driving Directions »

BioIncept Summary

ABOUT

Overview

BioIncept is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes and autoimmune diseases. BioIncept was founded in 2001. BioIncept's headquarters is located in New York, New York, USA 10017. BioI...

CEO

BioIncept's CEO, Brian K. Foster, currently has an approval rating of 88%. BioIncept's primary competitors are IM Therapeutics, ChemoCentryx & Curavac.

Acquisitions

There have been no acquisitions found related to BioIncept

Investments

Recent investment data cannot be found related to BioIncept

Frequently Asked Questions about BioIncept

  1. When was BioIncept founded?

    BioIncept was founded in 2001
  2. Who is BioIncept's CEO?

    BioIncept's CEO is Brian K. Foster
  3. How much revenue does BioIncept generate?

    BioIncept generates $7.3M in revenue
  4. How much funding does BioIncept have?

    BioIncept has historically raised $15.6M in funding
  1. Where is BioIncept's headquarters?

    BioIncept's headquarters is in New York New York, USA
  2. How many employees does BioIncept have?

    BioIncept has 25 employees
  3. What sector does BioIncept operate in?

    BioIncept is in Pharmaceuticals
  4. Who are BioIncept's competitors?

    BioIncept's top competitors are IM Therapeutics, ChemoCentryx, Curavac

Trending Companies